GlassScriptPhysician profile
Matthew D Williams
NPI 1942219894
$39,727.65
in general payments reported to CMS, 2019-2025
21 companies · $21K in 2025
The $21K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $839 · 2021: $2,904 · 2022: $2,313 · 2023: $761 · 2024: $1,580 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $2,601 · Food and Beverage: $2,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,000.00 |
| Travel and Lodging | $2,600.54 |
| Food and Beverage | $2,485.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $20,967.71 | 2019-2025 | Comprehensive Shoulder System, Persona |
| Alon Medical Technology | $6,580.53 | 2019-2024 | |
| Wright Medical Technology, INC. | $4,882.50 | 2019 | |
| Encore Medical, LP | $2,545.03 | 2019-2024 | Djo Surgical |
| Arthrex, INC. | $1,166.58 | 2019-2024 | Arthrex |
| Xiros INC | $725.79 | 2022-2023 | |
| Smith+Nephew, INC. | $671.69 | 2019-2025 | Healicoil, Coblation, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $559.05 | 2021-2024 | Blueprint Patient Specific Instrumentation, Mako |
| Regeneron Pharmaceuticals, INC. | $506.29 | 2023-2025 | Eylea Hd, Eylea |
| Anika Therapeutics, INC. | $285.19 | 2022 | |
| Fx Shoulder Solutions, INC | $271.78 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $133.94 | 2025 | Eylea Hd |
| Biorez, INC. | $120.24 | 2022 | |
| Genentech USA, INC. | $77.64 | 2025 | Vabysmo |
| Depuy Synthes Sales INC. | $71.38 | 2023 | Speed |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $70.58 | 2024 | Inset System |
| Pacira Pharmaceuticals Incorporated | $23.30 | 2024 | Zilretta, Iovera, Exparel |
| Ethicon US, LLC | $20.24 | 2020 | |
| Arthrosurface Incorporated | $18.06 | 2019 | |
| Boston Scientific Corporation | $16.33 | 2025 | General - Pain Management |
| Ferring Pharmaceuticals INC. | $13.80 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.